128 related articles for article (PubMed ID: 3038400)
1. Hypotensive effects of the renin inhibitor (RI-78) and the converting enzyme inhibitor (teprotide) in conscious monkeys.
Takaori K; Hartley LH; Burton J
Clin Exp Hypertens A; 1987; 9(2-3):387-90. PubMed ID: 3038400
[TBL] [Abstract][Full Text] [Related]
2. Specific inhibition of renin by an angiotensinogen analog: studies in sodium depletion and renin-dependent hypertension.
Burton J; Cody RJ; Herd JA; Haber E
Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5476-9. PubMed ID: 6159648
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of the blood pressure lowering action of renin inhibition and comparison with angiotensin converting enzyme inhibition.
Blaine EH
J Hypertens Suppl; 1989 Apr; 7(2):S47-9. PubMed ID: 2666614
[TBL] [Abstract][Full Text] [Related]
4. Comparison of different drug interference with the renin-angiotensin system.
Hofbauer KG; Fuhrer W; Heusser C; Wood JM
J Cardiovasc Pharmacol; 1985; 7 Suppl 4():S62-8. PubMed ID: 2412016
[TBL] [Abstract][Full Text] [Related]
5. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
Case DB; Wallace JM; Keim HJ; Weber MA; Drayer JI; White RP; Sealey JE; Laragh JH
Am J Med; 1976 Nov; 61(5):790-6. PubMed ID: 185903
[TBL] [Abstract][Full Text] [Related]
6. Acute hypotensive responses to peptide inhibitors of renin in conscious monkeys: an effect on blood pressure independent of plasma renin inhibition.
Schaffer LW; Schorn TW; Winquist RJ; Strouse JF; Payne L; Chakravarty PK; de Laszlo SE; tenBroeke J; Veber DF; Greenlee WJ
J Hypertens; 1990 Mar; 8(3):251-9. PubMed ID: 2159506
[TBL] [Abstract][Full Text] [Related]
7. Effects of a renin inhibitor, SR 43845, and of captopril on blood pressure and plasma active renin in conscious sodium-replete macaca.
Lacour C; Cazaubon C; Roccon A; Segondy D; Wagnon J; Nisato D
J Hypertens Suppl; 1989 Apr; 7(2):S33-5. PubMed ID: 2666612
[TBL] [Abstract][Full Text] [Related]
8. The inhibition of rat renin in sodium depleted and renal hypertensive rats. Comparison of purified antibodies or Fab fragments against mouse submaxillary renin with SQ 20881, and the effect on blood pressure homeostasis.
Lykkegård S
Scand J Urol Nephrol Suppl; 1984; 79():17-22. PubMed ID: 6206557
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of renin in the primate Callithrix jacchus (common marmoset).
Hofbauer KG; Ménard J; Michel JB; Wood JM
Clin Exp Hypertens A; 1983; 5(7-8):1237-47. PubMed ID: 6196144
[TBL] [Abstract][Full Text] [Related]
10. Reversal by angiotensins II and III of the effects of converting enzyme inhibition on renal electrolyte excretion in rats.
Harris PJ; Munro JO
J Physiol; 1984 Jun; 351():491-500. PubMed ID: 6205144
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the acute hypotensive effects of renin inhibition, converting enzyme inhibition, and angiotensin II antagonism in rats.
Wood JM; Mah SC; Schnell C
J Cardiovasc Pharmacol; 1990; 16 Suppl 4():S60-4. PubMed ID: 1705630
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of blood pressure reduction by teprotide (SQ 20881) in rats.
Jaeger P; Ferguson RK; Brunner HR; Kirchertz EJ; Gavras H
Kidney Int; 1978 Apr; 13(4):289-96. PubMed ID: 651128
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic effects of the converting enzyme inhibitor teprotide in normal- and high-renin hypertension.
Niarchos AP; Pickering TG; Wallace JM; Case DB; Laragh JH
Clin Pharmacol Ther; 1980 Nov; 28(5):592-601. PubMed ID: 6160013
[TBL] [Abstract][Full Text] [Related]
14. Effects of the nonapeptide SQ 20.881 on the blood pressure of conscious normotensive and chronic hypertensive mice.
Svendsen UG
Acta Pathol Microbiol Scand A; 1977 Nov; 85(6):942-4. PubMed ID: 602780
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular actions of the primate-selective renin inhibitor, A-62198.
Kleinert HD; Martin D; Chekal M; Young G; Rosenberg S; Plattner JJ; Perun TJ
J Pharmacol Exp Ther; 1988 Sep; 246(3):975-9. PubMed ID: 3047366
[TBL] [Abstract][Full Text] [Related]
16. The importance of the renin-angiotensin system in the development and maintenance of hypertension in the two-kidney one-clip hypertensive rat.
Morton JJ; Wallace EC
Clin Sci (Lond); 1983 Apr; 64(4):359-70. PubMed ID: 6186428
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of the renin-angiotensin system in experimental hypertension, with a note on the measurement of angiotensin I, II and III during infusion of converting-enzyme inhibitor.
Morton JJ; Casals-Stenzel J; Lever AF; Millar JA; Riegger AJ; Tree M
Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):233S-241S. PubMed ID: 223615
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of renin: recent developments.
Hofbauer KG; Wood JM
Contrib Nephrol; 1984; 43():144-52. PubMed ID: 6207982
[No Abstract] [Full Text] [Related]
19. Effects of renin inhibition in the conscious primate Macaca fascicularis.
Hui KY; Knight DR; Nussberger J; Hartley LH; Vatner SF; Haber E
Hypertension; 1989 Nov; 14(5):480-7. PubMed ID: 2680962
[TBL] [Abstract][Full Text] [Related]
20. Time course of changes in plasma renin after blockade of the renin-system. Studies of conscious and anaesthetized, normal, adrenalectomized and spontaneously hypertensive rats.
Bing J; Poulsen K
Acta Pathol Microbiol Scand A; 1975 Sep; 83(5):454-66. PubMed ID: 170788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
